Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor
Authors:
- Gunjan SinghGSGunjan Singh
- Gita RadhakrishnanGRGita Radhakrishnan
- Kiran GuleriaKGKiran Guleria
- 22 July 2009
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 107 (2) , 130-134
Abstract
Objective: To compare the efficacy and adverse effects of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor (AMTSL).Methods: A double‐blind randomized trial of 300 women with a healthy singleton pregnancy allocated into 4 groups to receive either: 400 µg or 600 µg of sublingual misoprostol, 5 IU of intravenous oxytocin, or 200 µg of intravenous methylergometrine. The primary outcome measure was blood loss in the third and fourth stage of labor; secondary measures were duration of the third stage of labor, changes in hemoglobin levels, and adverse effects.Results: Patients who received 600 µg of misoprostol had the lowest blood loss (96.05 ± 21.1 mL), followed by 400 µg of misoprostol (126.24 ± 49.3 mL), oxytocin (154.7 ± 45.7 mL), and methylergometrine (223.4 ± 73.7 mL) (P < 0.01). Shortest mean duration of the third stage of labor (5.74 minutes) was with 600 µg of misoprostol, while methylergometrine had the longest (6.83 minutes) (P < 0.05). Pyrexia was observed in the misoprostol groups, and raised blood pressure in the methylergometrine group (P < 0.001). The 24‐hour postpartum hemoglobin level was similar among the groups (P > 0.05).Conclusion: Administration of 600 µg of sublingual misoprostol was more effective than 400 µg of misoprostol, intravenous oxytocin, and intravenous methylergometrine for AMTSL.Keywords
This publication has 21 references indexed in Scilit:
- Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in IndiaInternational Journal of Gynecology & Obstetrics, 2005
- Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean sectionInternational Journal of Gynecology & Obstetrics, 2005
- Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trialBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- A pilot‐randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of laborActa Obstetricia et Gynecologica Scandinavica, 2004
- Acute myocardial infarction produced by methylergometrine malcate-induced coronary vasospasam.Nihon Naika Gakkai Zasshi, 2004
- The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard managementBJOG: An International Journal of Obstetrics & Gynaecology, 2000
- Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trialThe Lancet, 1998
- Instability of (methyl)ergometrine in tropical climates: an overviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- The postpartum period: the key to maternal mortalityInternational Journal of Gynecology & Obstetrics, 1996
- The Bristol third stage trial: active versus physiological management of third stage of labour.BMJ, 1988